nct_id: NCT04197180
age: Adults
cancer_center_accrual_goal_upper: 0
data_table4: Interventional
drug_list:
  drug:
  - drug_name: 'Procedure: Hybrid Argon Plasma Coagulation'
long_title: 'HybridAPC for the Treatment of Gastric Low Grade Intraepithelial Neoplasia
  (LGIN): a Prospective, Multi-center Study'
management_group_list:
  management_group:
  - is_primary: Y
    management_group_name: Group1
oncology_group_list:
  oncology_group:
  - group_name: Group1
    is_primary: N
phase: NA
principal_investigator: ''
principal_investigator_institution: Chinese University of Hong Kong
program_area_list:
  program_area:
  - is_primary: Y
    program_area_name: Program1
protocol_id: 0
protocol_no: ''
protocol_target_accrual: 100
protocol_type: INTERVENTIONAL
prior_treatment_requirements:
- 'Inclusion Criteria:'
- "1. Low grade intraepithelial neoplasia of stomach with size\u226420 mm"
- 2. Endoscopic diagnosis suspected gastric LGIN with biopsy confirmed gastric LGIN
- 3. Endoscopic appearance according to Paris classification of Type 0-IIa, IIb or
  IIc
- 4. Patients with informed consent
- 'Exclude - Exclusion Criteria:'
- Exclude - 1. Patients who had previous endoscopic treatment (including APC, EMR,
  ESD) for gastric LGIN, HGIN or gastric carcinoma.
- Exclude - 2. Endoscopic evidence of ulcer
- Exclude - 3. Biopsy confirmed HGIN
- Exclude - 4. Endoscopic diagnosis suspected HGIN while biopsy confirmed LGIN
- Exclude - 5. Pregnancy
- Exclude - 6. informed consent not available
short_title: Hybrid APC for Gastric Low Grade Intraepithelial Neoplasia
site_list:
  site: []
sponsor_list:
  sponsor:
  - is_principal_sponsor: Y
    sponsor_name: Chinese University of Hong Kong
    sponsor_protocol_no: ''
    sponsor_roles: sponsor
staff_list:
  protocol_staff: []
status: open to accrual
summary: This cohort study aims to investigate the clinical efficacy and safety of
  Hybrid APC for treatment of gastric low grade intramucosal neoplasia.
treatment_list:
  step:
  - arm:
    - arm_code: Hybrid Argon Plasma Coagulation
      arm_internal_id: 0
      arm_description: The Hybrid-Argon Plasma Coagulation probe combines waterjet
        technology with Argon Plasma Coagulation. The probe comprises a central water
        channel for the submucosa injection function and a peripheral gas channel
        for the Argon Plasma Coagulation function
      arm_suspended: N
      dose_level:
      - level_code: '0'
        level_description: 'Procedure: Hybrid Argon Plasma Coagulation'
        level_internal_id: 0
        level_suspended: N
    match:
    - and:
      - clinical:
          oncotree_primary_diagnosis: ''
          disease_status:
          - ''
          - ''
      - genomic:
          hugo_symbol: ''
          variant_category: ''
